Via practica 1/2009

The transferability of pharmacoeconomic studies results between countries

A growing number of jurisdictions now request economic data in support of their decision-making procedures for the pricing and/or reimbursement of health technologies. There are many reasons why the cost-effectiveness of health technologies might vary from place to place. Therefore, this report of an ISPOR Good Practices Task Force say also about transferability, discusses which elements of data could potentially vary from place to place and recommends good research practices for dealing with aspects of transferability, including strategies based on the analysis of individual patient data and based on decision-analytic modeling.

Keywords: data transferability, cost-effectiveness, economic data